#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Andersen-Tawil syndrome Monogenic diabetes Niemann-Pick disease Pemphigus Acute lymphocytic leukaemia recurrent Diffuse large B-cell lymphoma recurrent Cushing's syndrome Leiomyosarcoma MELAS syndrome Mitochondrial DNA depletion Mastocytosis Fms-like tyrosine kinase 3 positive Immune thrombocytopenia CDKL5 deficiency disorder Astrocytoma More trials…

    Learn about Rare Diseases

    Phenylketonuria – Trials in Disease Sarcoma – Basic Information Amyotrophic lateral sclerosis – Basic Information Mucopolysaccharidosis II – Treatment Alagille syndrome Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Anaplastic thyroid cancer – Life with Disease Netherton’s syndrome – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Lymphangioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anselamimab TRONTINEMAB Hct116-A Acoramidis Hydrochloride Vh4524184 Bi 1839100 [14C] DC-806 Ofloxacin ALE.P03 Lorazepam ATOVAQUONE Nazartinib Psilocybine Lt3001 Regadenoson Iti-1284 Ngi226 Nirogacestat Hydrobromide Air, Medicinal ALLERGEN EXTRACTS More therapies…

    Learn about Your Condition

    Endotracheal intubation Staphylococcal bacteraemia Primary hyperthyroidism Iron overload Chronic sinusitis Urinary tract infection Tendon injury Basal cell naevus syndrome Cardiomyopathy Retroperitoneal cancer Renal transplant Basal cell carcinoma Pre-eclampsia Osteoporosis Myocardial ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

    Recruiting

    2 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Germany Poland

  • Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Bulgaria Czechia Denmark France Germany Greece +7

  • Comparing diclofenac sodium eye drops versus dexamethasone phosphate eye drops for recovery after vitrectomy in patients with macular disorders

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Diclofenac Sodium
    • Triamcinolone Acetonide
    Belgium

  • Study of inavolisib, letrozole and ribociclib in untreated early-stage breast cancer patients with PIK3CA mutation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Inavolisib
    • Letrozole
    • Ribociclib
    Germany Spain

  • Study of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Raludotatug Deruxtecan
    • Ifinatamab Deruxtecan
    • Docetaxel
    Germany Greece Hungary Italy Poland Spain

  • Evaluating Different Durations of Antibiotic Treatment for Respiratory Tract Infections and Rhinosinusitis in Adults Receiving Beta-lactam Antibiotics

    Recruiting

    3 1 1 1
    Spain
Previous Page
1 … 154 155 156 157 158 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!